Prognostic signature of protocadherin 10 methylation in curatively resected pathological stage I non-small-cell lung cancer

Although curative resection is the current treatment of choice for localized non-small-cell lung cancer (NSCLC), patients show a wide spectrum of survival even after complete resection of pathological stage I NSCLC. Thus, identifying molecular biomarkers that help to accurately select patients at hi...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Cancer Med
Autori principali: Harada, Hiroaki, Miyamoto, Kazuaki, Yamashita, Yoshinori, Taniyama, Kiyomi, Mihara, Kazuko, Nishimura, Mitsuki, Okada, Morihito
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley & Sons, Ltd 2015
Soggetti:
Clinical Cancer Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4618624/
https://ncbi.nlm.nih.gov/pubmed/26276761
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.507
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi